Name | (2R)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol |
---|---|
Synonyms |
L-Valine, L-phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-L-leucyl-
L-Phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-L-leucyl-L-valine |
Description | MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C53H79N13O10 |
Molecular Weight | 1058.276 |
Exact Mass | 1057.607300 |
PSA | 365.02000 |
LogP | 4.48 |
Index of Refraction | 1.642 |